OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study
Xinpeng Wang, Lvjuan Cai, Mengjing Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Xinpeng Wang, Lvjuan Cai, Mengjing Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Showing 3 citing articles:
Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers
Zhihao Lu, Mingfei Geng, Yongtao Han, et al.
Cancer Biology and Medicine (2025) Vol. 21, Iss. 12, pp. 1171-1184
Open Access | Times Cited: 1
Zhihao Lu, Mingfei Geng, Yongtao Han, et al.
Cancer Biology and Medicine (2025) Vol. 21, Iss. 12, pp. 1171-1184
Open Access | Times Cited: 1
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis
Bao‐Wen Tian, Cheng‐Long Han, Hanchao Wang, et al.
Clinical & Experimental Metastasis (2023) Vol. 40, Iss. 4, pp. 255-287
Closed Access | Times Cited: 13
Bao‐Wen Tian, Cheng‐Long Han, Hanchao Wang, et al.
Clinical & Experimental Metastasis (2023) Vol. 40, Iss. 4, pp. 255-287
Closed Access | Times Cited: 13
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study
Lin Yu, Wenbin Shen, Jinjun Ye, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Lin Yu, Wenbin Shen, Jinjun Ye, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
